Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Reach Grant

    Forecasted

    Reach Grant supports researchers conducting late-translational childhood cancer studies to overcome preclinical barriers and advance promising work toward phase I and/or II clinical trials.

    Browse similar grants
    Cancer Research Grants 2026Foundation Grants for Biomedical Research
    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: Alex's Lemonade Stand Foundation

    Due Dates (Anticipated): April 2027 (Full application)

    Funding Amounts: Up to $250,000 USD over two years; maximum $125,000 per year in direct costs

    Summary: Supports hypothesis-driven, late-translational childhood cancer research needed to advance toward phase I and/or II clinical trials.

    Key Information: A clinical development plan is required; clinical trial expenses are not funded.


    Description

    Alex’s Lemonade Stand Foundation’s Reach Grant supports preclinical research that removes barriers to translating promising childhood cancer studies into clinical trials. The goal is to advance projects toward a phase I and/or II trial within two to three years after the funded project ends. Appropriate work includes completing IND-enabling studies, generating preclinical data needed for trial development, and validating biomarkers for patient selection.

    The program focuses on feasible, hypothesis-driven, late-translational studies grounded in preliminary data. Proposals must include milestones, time-based deliverables, and a plan for clinical development. Projects with a clear clinical trial plan receive priority. Screening, discovery, and early-translational projects are outside the program’s scope.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.